StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)

Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –

Medpace cash

Cash and short-term investments held at the end of each period.

Medpace's cash was $705.32M at Sep 30, 2026. For fiscal 2025 it was $497.05M, down 25.8% from the year before. Over ten years it grew 39.6% a year on average. The highest annual figure on record is $669.44M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$497.05M-25.8%
FY2024Dec 31, 2024$669.44M+172.7%
FY2023Dec 31, 2023$245.45M+768.4%
FY2022Dec 31, 2022$28.27M-93.9%
FY2021Dec 31, 2021$461.30M+66.1%
FY2020Dec 31, 2020$277.77M+110.6%
FY2019Dec 31, 2019$131.92M+466.6%
FY2018Dec 31, 2018$23.28M-12.1%
FY2017Dec 31, 2017$26.49M-29.2%
FY2016Dec 31, 2016$37.41M+110.9%
FY2015Dec 31, 2015$17.74M-68.0%
FY2014Dec 31, 2014$55.39M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$705.32M+147.2%
Q2 FY2026Jun 30, 2026$502.69M+985.0%
Q1 FY2026Mar 31, 2026$652.68M+47.9%
Q4 FY2025Dec 31, 2025$497.05M-25.8%
Q3 FY2025Sep 30, 2025$285.35M-56.6%
Q2 FY2025Jun 30, 2025$46.33M-90.9%
Q1 FY2025Mar 31, 2025$441.44M+8.5%
Q4 FY2024Dec 31, 2024$669.44M+172.7%
Q3 FY2024Sep 30, 2024$656.90M+590.0%
Q2 FY2024Jun 30, 2024$510.89M+1205.4%
Q1 FY2024Mar 31, 2024$407.01M+767.4%
Q4 FY2023Dec 31, 2023$245.45M+768.4%
Q3 FY2023Sep 30, 2023$95.21M+207.1%
Q2 FY2023Jun 30, 2023$39.14M-8.0%
Q1 FY2023Mar 31, 2023$46.92M-43.4%
Q4 FY2022Dec 31, 2022$28.27M-93.9%
Q3 FY2022Sep 30, 2022$31.01M-92.2%
Q2 FY2022Jun 30, 2022$42.55M-87.4%
Q1 FY2022Mar 31, 2022$82.84M-75.1%
Q4 FY2021Dec 31, 2021$461.30M+66.1%
Q3 FY2021Sep 30, 2021$398.39M+81.7%
Q2 FY2021Jun 30, 2021$339.01M+110.7%
Q1 FY2021Mar 31, 2021$332.88M+148.4%
Q4 FY2020Dec 31, 2020$277.77M+110.6%
Q3 FY2020Sep 30, 2020$219.23M+176.5%
Q2 FY2020Jun 30, 2020$160.90M+700.6%
Q1 FY2020Mar 31, 2020$134.00M+344.8%
Q4 FY2019Dec 31, 2019$131.92M+466.6%
Q3 FY2019Sep 30, 2019$79.29M+256.5%
Q2 FY2019Jun 30, 2019$20.10M-9.6%
Q1 FY2019Mar 31, 2019$30.13M+35.4%
Q4 FY2018Dec 31, 2018$23.28M-12.1%
Q3 FY2018Sep 30, 2018$22.24M-8.3%
Q2 FY2018Jun 30, 2018$22.23M-24.2%
Q1 FY2018Mar 31, 2018$22.25M-24.8%
Q4 FY2017Dec 31, 2017$26.49M-29.2%
Q3 FY2017Sep 30, 2017$24.25M–
Q2 FY2017Jun 30, 2017$29.33M–
Q1 FY2017Mar 31, 2017$29.61M–
Q4 FY2016Dec 31, 2016$37.41M–

More Medpace figures

See a number that looks wrong?